V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.
Saved in:
| Title: | V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology. |
|---|---|
| Authors: | Erdélyi LS; Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary., Hunyady L; Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; Institute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary., Balla A; Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; ELKH-SE Laboratory of Molecular Physiology, Eötvös Loránd Research Network, Budapest, Hungary. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 May 24; Vol. 14, pp. 1173601. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2023.1173601 |
